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Abstract
Background: Identical DNA methylation differences between maternal and paternal alleles in
gametes and adults suggest that the inheritance of genomic imprints is strictly due to the embryonic
maintenance of DNA methylation. Such maintenance would occur in association with every cycle
of DNA replication, including those of preimplantation embryos.
Results: The expression of the somatic form of the Dnmt1 cytosine methyltransferase (Dnmt1s)
was examined in cleavage-stage preimplantation mouse embryos. Low concentrations of Dnmt1s
are found in 1-, 2-, 4-, and 8-cell embryos, as well as in morulae and blastocysts. Dnmt1s is present
in the cytoplasm at all stages, and in the nuclei of all stages except the 1-cell, pronuclear-stage
embryo. The related oocyte-derived Dnmt1o protein is also present in nuclei of 8-cell embryos,
along with embryo-synthesized Dnmt1s. Dnmt1s protein expressed in 1-cell and 2-cell embryos is
derived from the oocyte, whereas the embryo synthesizes its own Dnmt1s from the 2-cell stage
onward.
Conclusion: These observations suggest that Dnmt1s provides maintenance methyltransferase
activity for the inheritance of methylation imprints in the early mouse embryo. Moreover, the
ability of Dnmt1o and Dnmt1s proteins synthesized at the same time to substitute for one
another's maintenance function, but the lack of functional interchange between oocyte- and
embryo-synthesized Dnmt1 proteins, suggests that the developmental source is the critical
determinant of Dnmt1 function during preimplantation development.
Background
Genomic imprinting is an epigenetic process that distin-
guishes parental alleles in nuclei of diploid cells. Such an
imprinted state must come about by first epigenetically
distinguishing the two alleles in the parental gametes.
Afterwards, oocyte- and sperm-specific epigenetic marks
are perpetuated as cells divide during embryogenesis. For
many reasons, DNA cytosine methylation is an excellent
candidate for this epigenetic distinction [1]. First, alleles
of most imprinted genes are differentially methylated in
embryonic and adult tissues. Second, this DNA methyla-
tion difference first appears between alleles in the parental
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germ lines, suggesting that the embryo inherits patterns of
DNA methylation established in the gametes. Third, the
process whereby parental imprints are established de
novo in the germ cells is catalyzed by a cytosine methyl-
transferase [2]. Lastly, the perpetuation of DNA methyla-
tion patterns on imprinted genes in the post-implantation
embryo is absolutely dependent on the maintenance
methyltransferase activity of the somatic variant of a dif-
ferent cytosine methyltransferase, Dnmt1 [3].
Although DNA methylation's function in establishing
imprints in the gametes, and in perpetuating these after
implantation of the embryo is well established, the role of
DNA methylation during the intervening preimplantation
stages of embryo development is much less certain. The
Dnmt1o variant of Dnmt1, which is synthesized in
oocytes, traffics from the cytoplasm to the nuclei of 8-cell
embryos, where it maintains genomic imprints [4,5].
However, this maternally derived protein is excluded from
the nuclear compartment of preimplantation embryos at
non-8-cell stages [5], and the longer somatic variant of
Dnmt1, Dnmt1s, was not detected in wild-type preim-
plantation embryos [6]. These observations suggest that
Dnmt1s may be present in preimplantation embryos, but
in concentrations that we did not detect using particular
immunodetection methods [6]. An alternative possibility
is that the maintenance of genomic imprints at non-8-cell
stages of preimplantation development occurs by non-
Dnmt1 maintenance mechanisms.
We had previously detected the Dnmt1s protein in nuclei
of 4-cell, 8-cell and 16-cell embryos that developed in the
absence of maternal Dnmt1o protein [7]. These observa-
tions suggested that the loss of Dnmt1o from early
embryos resulted in a compensatory increase in expres-
sion of Dnmt1s protein that then trafficked readily into
nuclei of many cleavage-stage embryos, where this con-
centrated nuclear Dnmt1 was detected by immunostain-
ing. Because of this detection of Dnmt1s protein in
embryos lacking Dnmt1o, and because of the absence of
experimental support for an alternative mechanism to
explain the inheritance of methylation patterns associated
with imprinted alleles, we used an improved immunode-
tection method to explore the possibility that Dnmt1s is
expressed in wild-type preimplantation embryos.
Results
Dnmt1s is present in fully grown oocytes
We explored the possibility that the Mr 190,000 Dnmt1s
form of Dnmt1 is expressed during preimplantation
development in wild-type embryos by using an antiserum
that binds specifically to Dnmt1s [6], by using appropri-
ate controls for the specificity of immunodetection and by
using a different Dnmt1s immunodetection technique.
Two different polyclonal antisera were used in these stud-
ies. UPT82 is a rabbit polyclonal antiserum that binds to
epitopes in the N terminus of Dnmt1s that are not found
in the smaller Dnmt1o protein [6]. In contrast, UPTC21 is
a chicken polyclonal antiserum that recognizes both the
Dnmt1s and the Dnmt1o proteins [6] (Figure 1A).
To examine Dnmt1s expression during oogenesis, immu-
noblots were produced using extracts from different types
of oocytes, and these were first probed with UPT82. To
ensure detection of Dnmt1s protein and the accurate com-
parison of Dnmt1s in different developmental stages, we
used extracts of approximately 100 wild-type oocytes per
lane. Dnmt1s was present at an approximately 10-fold
higher concentration in GV-stage oocytes compared to
MII oocytes (Figure 1B). Significant increases in the level
of Dnmt1s were seen in homozygous MII oocytes of two
different mutant mouse lines, the Dnmt11s/1o line that syn-
thesizes both the Dnmt1s and Dnmt1o proteins from a
single, modified Dnmt1o transcript [6], and the Dnmt1∆1o
line that does not produce the Dnmt1o protein [5]. The
approximately 40-fold increase in Dnmt1s concentration
in Dnmt1o-deficient oocytes compared to wild-type MII
oocytes most likely is due to an increase in Dnmt1s syn-
thesis. In addition, more Dnmt1s protein is present in MII
oocytes from the TgEL  transgenic line that expresses
Dnmt1s from transcripts synthesized using the trans-
gene's zona pellucida 3 (Zp3) promoter (Figure 1B). A high
level of Dnmt1o protein expression in wild-type GV-stage
and MII oocytes, a relatively lower level of Dnmt1o in
homozygous Dnmt11s/1o MII oocytes, and the absence of
Dnmt1o expression in homozygous Dnmt1∆1o/∆1o  MII
oocytes were shown using the UPTC21 antiserum (Figure
1C). The absence of detectable oocyte Dnmt1s protein
with UPTC21 indicates that UPT82 is more sensitive than
UPTC21 in detecting the Dnmt1s protein.
Dnmt1s is present throughout preimplantation 
development
Dnmt1s protein was also observed in all preimplantation
embryo stages examined (Figure 2A). These included 1-
cell, 2-cell, 4-cell, 8-cell embryos, as well as blastocysts.
The concentration of Dnmt1s in 1-cell embryos was simi-
lar to that seen in wild-type MII oocytes. A nadir of
Dnmt1s concentration was seen in wild-type 2-cell and 4-
cell embryos. Thereafter, the preimplantation Dnmt1s
concentration rose to a maximum in blastocysts. The con-
centration of Dnmt1s in the blastocyst was approximately
7 times the MII-oocyte concentration and approximately
18 times the 4-cell concentration. The pattern of changes
in Dnmt1s protein concentration seen throughout preim-
plantation development suggests that preimplantation
Dnmt1s is derived from a combination of maternal and
zygotic protein synthesis. The source of an embryo's
Dnmt1s would most likely change from maternal to
zygotic near the nadir of Dnmt1s concentration, namelyBMC Developmental Biology 2008, 8:9 http://www.biomedcentral.com/1471-213X/8/9
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at the 2-cell or 4-cell cleavage stages. This notion is con-
sistent with previous observations in which Dnmt1s
mRNA is present in MII oocytes and throughout preim-
plantation development, with a nadir in Dnmt1s mRNA
concentration at the 1-cell stage [6].
The Dnmt1o and Dnmt1s proteins present in the MII
oocyte may serve different functions in early embryos.
Dnmt1o is a maternal-effect protein that maintains
genomic imprints during preimplantation development,
probably at the 8-cell stage where Dnmt1o traffics into
nuclei [5]. Maternal Dnmt1s might provide a different
function in maintaining DNA methylation in the early
embryo, perhaps earlier than the 8-cell stage. In support of
this notion, the concentrations of Dnmt1o and Dnmt1s
change in very different ways from the MII oocyte stage to
the 8-cell stage. 8-cell Dnmt1o is one-sixth the level of
Dnmt1o seen in MII oocytes, whereas the concentration
of Dnmt1s in 8-cell embryos is only 1/30th that of MII-
oocyte Dnmt1s. This represents a 5-fold higher rate of
decline in Dnmt1s protein concentration than Dnmt1o's
rate of decline (Figure 2B). 8-cell Dnmt1o protein is likely
to be entirely oocyte-derived, because Dnmt1o transcripts
disappear from the embryo after the 1-cell stage [6]. The
relatively slow rate of decline in Dnm1o protein concen-
tration during the first half of preimplantation develop-
ment is consistent with a highly stable protein, similar to
the highly stable nature of Dnmt1o when it is expressed in
somatic tissues of Dnmt1V  mice [8]. In contrast, the
Dnmt1s protein appears to be much less stable during
preimplantation development. Oocyte-derived Dnmt1s
may be even less stable than indicated by the oocyte/8-cell
ratio; any Dnmt1s synthesized in the early preimplanta-
tion embryo would contribute to the 8-cell Dnmt1s level,
and falsely raise the calculated stability of MII-oocyte
Dnmt1s protein. We conclude from this analysis that MII-
Dnmt1o and Dnmt1s forms of Dnmt1 protein and their expression in oocytes Figure 1
Dnmt1o and Dnmt1s forms of Dnmt1 protein and their expression in oocytes. A. Schematic representation of the 
mouse Dnmt1s and Dnmt1o proteins. Near the N-termini two regions are highlighted, the PCNA binding domain (PBD) and 
targeting sequence (TS) that have been implicated in targeting Dnmt1 to replication foci [18,29]. The black rectangles identify 
the positions of the mouse Dnmt1s amino acid sequences used to immunize a rabbit to produce the UPT82 antiserum or to 
immunize a chicken to produce the UPTC21 antiserum [6]. B. Immunoblots showing expression of Dnmt1s protein in oocytes 
from various mouse lines. The upper and lower blots were probed with the UPT82 antiserum. + refers to wild-type oocytes; 
1s/1o refers to homozygous mutant oocytes from the Dnmt11s/1o strain [6]; ∆1o refers to homozygous mutant oocytes from 
the Dnmt1∆1o strain; TgEL/+ refers to oocytes from hemizygous TgEL transgenic mice. Sample sizes for the upper blot: 100 wild-
type GV oocytes; 120 wild-type MII oocytes; 25 1s/1o oocytes; 60 ∆1o oocytes. Sample sizes for the lower blot: 105 wild-type 
MII oocytes; 40 TgEL/+ oocytes. C. Expression of Dnmt1o protein in wild-type, 1s/1o and ∆1o oocytes. The same blot shown in 
panel B was probed with UPTC21.BMC Developmental Biology 2008, 8:9 http://www.biomedcentral.com/1471-213X/8/9
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oocyte Dnmt1s is unstable during the first half of preim-
plantation development (by at least a factor of five) com-
pared to MII-oocyte Dnmt1o protein.
Dnmt1o protein in MII oocytes was readily detected on
immunoblots using the UPTC21 antibody, but oocyte
Dnmt1s was not detected using UPTC21 (Figure 1C).
Because of the inability to detect both forms of the protein
in oocytes with the same antibody, a quantitative differ-
ence in the concentrations of the two proteins was not
established. To indirectly establish an estimate of a func-
tional difference between the two forms in oocytes, we
measured the maintenance methyltransferase activity in
oocytes of difference genotypes. As shown in Figure 2C,
97.4% to 99.0% of MII oocyte maintenance methyltrans-
ferase activity was due to the presence of the Dnmt1o pro-
tein. This represents an approximately 50-fold reduction
of maintenance methyltransferase activity in homozygous
Dnmt1∆1o/∆1o oocytes compared to wild-type oocytes. The
approximately 2% of normal MII oocyte maintenance
activity not attributed to Dnmt1o is probably Dnmt1s
activity. Because the oocyte concentration of Dnmt1s was
increased by a factor of 40 in the absence of Dnmt1o (Fig-
ure 1B), the amount of methyltransferase activity actually
attributable to Dnmt1s in wild-type oocytes is more likely
to be 0.05% of the total maintenance methyltransferase
activity. In cultured somatic cells, the specific mainte-
nance methyltransferase activities of Dnmt1s and
Dnmt1o are the same [9]. If we assume that the specific
activities are also the same in MII oocytes, then we can
infer that the concentration of the Dnmt1s protein in MII
oocytes is approximately 1/2000th of the Dnmt1o protein
concentration. Such a low relative abundance of Dnmt1s
protein probably accounts for our inability to previously
detect it in wild-type oocytes [6].
The normal oocyte maintenance methyltransferase activ-
ity can be increased approximately 2-fold in TgEL oocytes
(Figure 2C). TgEL  MII oocytes had approximately 13
times the level of Dnmt1s protein compared to wild-type
MII oocytes when the protein levels are estimated from an
immunoblot probed with the UPT82 antibody (Figure
1B). The cause of this discrepancy between the modest
increase in maintenance methyltransferase activity and
the large increase in protein level relative to the wild-type
amount of Dnmt1o protein is unknown. TgEL-derived
Dnmt1s protein contains an additional 46 amino acids at
its amino terminus, and these amino acids are adjacent to
Dnmt1s protein expression during preimplantation development Figure 2
Dnmt1s protein expression during preimplantation development. A. Relative amount of Dnmt1s protein in fully 
grown wild-type MII oocytes, and in embryos at different stages of development. MII = MII oocytes; 1 = 1-cell; 2 = 2-cell; 4 = 4-
cell; 8 = 8-cell; Bl = blastocyst. Sample sizes: 105 wild-type MII oocytes; 105 1-cell embryos; 110 2-cell embryos; 110 4-cell 
embryos; 110 8-cell embryos; 120 blastocysts. B. Relative stability of oocyte-derived Dnmt1o and Dnmt1s proteins from 
homozygous Dnmt11s/1o mice during preimplantation development to the 8-cell stage. Sample sizes: 22 MII oocytes; 21 8-cell 
embryos. The blot was first probed with UPT82, stripped and then reprobed with UPTC21. The assay was repeated, and 
nearly identical results were obtained (data not shown). C. Relative levels of maintenance methyltransferase activity (MA) per 
oocyte. MA is expressed as [3H]methyl group incorporation into the synthetic template poly(dIdC). Oocyte genotype is the 
genotype of the diploid precursor of the analyzed MII oocyte. The assay was performed on three separate occasions (1–3). The 
background measurement is the cpm in sample containing poly(dIdC) and S-adenosyl methionine, but no oocyte extract. 
Dnmt1o MA/Total MA was calculated as [(Dnmt1+/+ – background) – (Dnmt1∆1o/∆1o – background)]/(Dnmt1+/+ – background), 
expressed as a percentage.BMC Developmental Biology 2008, 8:9 http://www.biomedcentral.com/1471-213X/8/9
Page 5 of 14
(page number not for citation purposes)
the 118-aa region containing epitopes detected by the
UPT82 antibody. It is unlikely that the addition of 46
amino acids to the amino terminus of Dnmt1s would
influence its innate biochemical methyltransferase activ-
ity. It is more likely that either the additional 46 amino
acids negatively affect the sensitivity of detection of the
transgene protein or that the ooplasmic transgene protein
is more enzymatically active than the abundant, stored
Dnmt1o protein. The latter effect could occur if the major-
ity of the ooplasmic Dnmt1o is enzymatically inactive,
whereas the majority of the transgene Dnmt1s protein is
enzymatically active.
Intracellular localization of preimplantation Dnmt1s 
protein
As shown in Figure 3A, the UPT82 antiserum stains nuclei
of mouse embryonic fibroblasts (MEFs) from hetero-
zygous Dnmt1V/+ embryos, but does not stain nuclei of
homozygous Dnmt1V/V MEFs. Moreover, the Dnmt1s pro-
tein is not detected on immunoblots of homozygous
Dnmt1V/V somatic tissues probed with the UPTC21 anti-
body [8]. These observations indicate that UPT82 specifi-
cally identifies Dnmt1s in cells. In light of these
observations, we stained wild-type pronuclear-stage 1-cell
embryos with UPT82 and showed that Dnmt1s is present
throughout the cytoplasm. Nuclear staining was not
observed. As expected, no staining at all was evident in
homozygous  Dnmt1V/V  embryos derived from crosses
between a Dnmt1V/V female and a Dnmt1V/Vmale. The spe-
cific cytoplasmic staining seen in 1-cell embryos was true
of early pronuclear stages (data not shown for PN1 and
PN2 stages), as well as the later PN3 and PN4 stages (Fig-
ure 3B). In PN-stage 1-cell embryos derived from Dnmt11s/
1o and TgEL oocytes, which produce greater than normal
amounts of Dnmt1s, cytoplasmic Dnmt1s staining was
significantly higher than nuclear Dnmt1s staining (Figure
3B). Finally, when pronuclear-stage 1-cell embryos were
stained with the UPTC21 antibody, there was intense
cytoplasmic staining for Dnmt1o, but no pronuclear
staining was evident (Figure 3C). This cytoplasmic locali-
zation of Dnmt1o has been previously described [10,11].
Dnmt1s staining was seen in wild-type 2-cell, 4-cell and 8-
cell embryos, as well as in nuclei of wild-type morulae and
blastocysts (Figure 4A). In contrast to the cytoplasm-spe-
cific staining of pronuclear-stage 1-cell embryos, the stain-
ing of the later stages was concentrated in the nuclei. We
conclude from this analysis that Dnmt1s protein is
expressed in all stages of preimplantation development,
primarily in nuclei of cells at all stages except the pronu-
clear stages of the 1-cell embryo.
Dnmt1s is derived from two sources
One likely cause for the varying levels of Dnmt1s protein
during preimplantation development (Figure 2A) would
be that levels during this developmental window are
determined by a combination of oocyte (maternal) syn-
thesis and post-fertilization (zygotic) synthesis. To
explore this possibility, preimplantation embryos derived
from crosses between wild-type and Dnmt1V mice were
examined. In 1-cell, 2-cell, 4-cell and 8-cell embryos
derived from crosses between homozygous Dnmt1V/V
mutant female mice and wild-type male mice, Dnmt1s
was present in 2-cell, 4-cell and 8-cell embryos (including
in the nuclei), but not in 1-cell embryos (Figure 4B).
Because these embryos should only synthesize Dnmt1s
zygotically from the paternal allele, we interpret these
results as indicating that the Dnmt1s in wild-type 1-cell
embryos is of maternal (oocyte) origin, and Dnmt1s pro-
tein seen afterwards at least partially originates from
zygotic (post-fertilization) synthesis.
To establish the duration of expression of the maternally
derived Dnmt1s protein beyond the 1-cell stage, we exam-
ined embryos from crosses between heterozygous
Dnmt1V/+ females and homozygous Dnmt1V/V males. One-
half of embryos from this cross will synthesize only mater-
nal Dnmt1s, whereas the other half will synthesize
Dnmt1s both maternally and zygotically. When a series of
2-cell embryos were examined, all stained for cytoplasmic
and nuclear Dnmt1s (Figure 4C). However, when a series
of 4-cell and a series of 8-cell embryos were stained,
approximately one-half of the embryos expressed both
nuclear and cytoplasmic Dnmt1s, whereas the other half
showed no significant staining (Figure 4C). These results
are consistent with expression of maternal Dnmt1s
through the 2-cell stage, but not beyond. Taken together
with the results of Dnmt1s expression in offspring of
crosses between wild-type females and Dnmt1V/V males,
these findings are also consistent with a zygotic origin of
Dnmt1s found in 2-cell embryos and beyond.
Oocyte-derived Dnmt1s restores imprinting in Dnmt1o-
deficient embryos
Both the Dnmt1s and the Dnmt1o forms of Dnmt1 pro-
tein are present in nuclei of 8-cell blastomeres (Figures
4A) [7]. Despite this, in embryos derived from
homozygous mutant Dnmt1∆1o/∆1o female mice, loss of
Dnmt1o from nuclei of 8-cell blastomeres was not func-
tionally compensated for Dnmt1s. It would appear there-
fore that Dnmt1s in nuclei of 8-cell blastomeres does not
function to maintain methylation patterns on differen-
tially methylated domains (DMDs) associated with
imprinted genes. Because 8-cell nuclear Dnmt1o is of
maternal origin and 8-cell nuclear Dnmt1s is of zygotic
origin, it is possible that the zygotic origin of 8-cell
nuclear Dnmt1s precludes its function in nuclei of 8-cell
embryos. In view of this, we explored the possibility that
oocyte-derived Dnmt1s can replace Dnmt1o in maintain-
ing genomic imprints.BMC Developmental Biology 2008, 8:9 http://www.biomedcentral.com/1471-213X/8/9
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The TgEL transgenic line expresses an epitope-tagged ver-
sion of Dnmt1s in MII oocytes (Figures 1B and 5A). The
TgEL-derived Dnmt1s is likely to be catalytically active in
vivo, because TgEL  MII oocytes have increased mainte-
nance methyltransferase activity (Figure 2C). The ability
of the TgEL oocyte-derived Dnmt1s to maintain embry-
onic imprints in the absence of Dnmt1o was tested by
crossing Dnmt1∆1o/∆1o, TgEL/+ mice with Cast-7 mice. The
Dnmt1∆1o allele and the TgEL transgene were both crossed
into the inbred FVB/N strain background. Nine crosses
each between Dnmt1∆1o/∆1o females or Dnmt1∆1o/∆1o, TgEL
females and Cast-7 males were established and main-
tained for 9 months. Six litters of live newborns were
obtained from the Dnmt1∆1o/∆1o, TgEL females, whereas no
live newborns were obtained from the Dnmt1∆1o/∆1o
females. Only a total of 14 live offspring were obtained
from the six litters born to Dnmt1∆1o/∆1o, TgEL female mice
(litters of 4, 4, 2, 2, 1, and 1 offspring). These results indi-
cate that the presence of the TgEL transgene in the female
parent had a beneficial effect on recovering viable off-
spring.
To explore the possibility that the beneficial effect of
Dnmt1s expression in Dnmt1o-deficient oocytes was due
to a Dnmt1s rescue of Dnmt1o-catalyzed maintenance of
genomic imprints in the early embryo, we examined the
methylation and expression of imprinted genes in off-
spring of Dnmt1∆1o/∆1o, TgEL female mice. Methylation of
Immunolocalization of Dnmt1o and Dnmt1s proteins in mouse embryonic fibroblasts and 1-cell embryos Figure 3
Immunolocalization of Dnmt1o and Dnmt1s proteins in mouse embryonic fibroblasts and 1-cell embryos. A. 
Immunostaining of primary embryonic fibroblasts from either heterozygous Dnmt1V/+ (V/+) or homozygous Dnmt1V/V (V/V) mice 
using the UPT82 antiserum. Intracellular DNA was detected with DAPI. B. Immunostaining of MII oocytes and pronuclear-
stage embryos of different genotypes with the UPT82 antiserum. PN3 and PN4 refer to pronuclear stage 3 and 4 as defined by 
morphologic criteria [17]. Insets are bright-field images of immunostained embryos. C. Immunostaining of pronuclear-stage 
embryos with the UPTC21 antiserum to detect the abundant Dnmt1o protein. Genotype abbreviations are the same as in the 
legends to Figures 1 and 2. Bar, 20 µm.BMC Developmental Biology 2008, 8:9 http://www.biomedcentral.com/1471-213X/8/9
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Expression of maternal and zygotic Dnmt1s during preimplantation development Figure 4
Expression of maternal and zygotic Dnmt1s during preimplantation development. A. Time course of Dnmt1s 
expression at defined preimplantation cleavage stages determined by immunostaining with the UPT82 antiserum. Mo = morula. 
Bl = blastocyst. B. Time course of Dnmt1s expression during preimplantation development in embryos derived from crosses 
between wild-type (+/+) female mice and homozygous Dnmt1V/V (V/V) male mice. Inset is bright-field image of immunostained 
1-cell embryo. C. Time courses of Dnmt1s expression during preimplantation development in embryos derived from crosses 
between heterozygous Dnmt1V/+ (V/+) female mice and homozygous Dnmt1V/V (V/V) male mice. The 4-cell and 8-cell embryos in 
the top row show primarily nuclear Dnmt1s staining whereas 4-cell and 8-cell embryos in the botton row show little or no 
nuclear Dnmt1s. All seven 2-cell, three out of seven 4-cell and six out of 13 8-cell embryos showed nuclear staining. Bar, 20 
µm.BMC Developmental Biology 2008, 8:9 http://www.biomedcentral.com/1471-213X/8/9
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H19 and Snurf/Snrpn DMDs was measured in four E13.5
embryos and four surviving adults (from a single litter)
derived from crosses between Dnmt1∆1o/∆1o, TgEL females
and wild-type Cast-7 males. As shown in Figure 5B, when
one E13.5 embryo (Embryo #4) and one adult (Adult #1)
were examined in detail, more paternal H19 alleles and
more maternal Snurf/Snrpn alleles were methylated in the
adult offspring than in the embryo. Stated differently, the
level of DNA methylation of Embryo #4 is more similar to
the level of methylation of an E13.5 embryo derived from
a Dnmt1∆1o/∆1o female mouse (Figure 5B) [5], whereas the
level of methylation of the H19 gene of Adult #1 is more
similar to the level of methylation in an adult mouse
derived from a TgEL female mouse (Figure 5B). This type
The forced expression of maternal Dnmt1s protein prevents loss of imprinting due to the absence of maternal Dnmt1o pro- tein Figure 5
The forced expression of maternal Dnmt1s protein prevents loss of imprinting due to the absence of maternal 
Dnmt1o protein. A. Schematic of construct used to force expression of an epitope-tagged version of Dnmt1s in fully grown 
mouse oocytes of the TgEL transgenic mouse line. ZP3 = 6.6-kb mouse zona pellucida 3 gene promoter [23]. Dnmt1s = full-
length Dnmt1s cDNA containing coding sequence for N-terminal Anti-Xpress epitope tag. BGH = bovine growth hormone 
polyadenylation and transcription termination sequence. B. Summary of bisulfite genomic sequencing of two normally 
imprinted genes in mice of various genotypes. Dnmt1∆1o/+ alleles were analyzed in a DNA sample isolated from an E13.5 
embryo derived from a cross between a homozygous Dnmt1∆1o/∆1o female and a Cast-7 male. Dnmt1∆1o/+, TgEL alleles were ana-
lyzed in DNA samples isolated either from an E13.5 embryo (Embryo #4) or from an adult (Adult #1) derived from crosses 
between a Dnmt1∆1o/∆1o, TgEL female and a Cast-7 male. C. Analysis of H19 and Snurf/Snrpn gene expression in mice of various 
genotypes. Allele-specific expression of H19 was determined by restriction endonuclease digestion of RT-PCR products. 
Allele-specific expression of Snurf/Snrpn was determined by SnuPE assay. Lanes 1–4: Dnmt1∆1o/+, TgEL E13.5 embryos, Embryo 
#1 through Embryo #4. Lane 5–6: Dnmt1∆1o/+ embryos. Lanes 7–10: Dnmt1∆1o/+, TgEL adults, Adult #1 through Adult #4. Lane 
11: inbred Cast-7. Lane 12: inbred FVB/N. Lane 13: F1 hybrid from cross between an FVB/N female mouse and a Cast-7 male 
mouse.BMC Developmental Biology 2008, 8:9 http://www.biomedcentral.com/1471-213X/8/9
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of analysis was carried out on an additional three embryos
and three adults, and the data summarized in Table 1. In
most instances the level of methylation among both
embryos and adults from Dnmt1∆1o/∆1o, TgEL female mice
was not significantly different than the extent of H19
paternal allele and Snurf/Snrpn maternal allele methyla-
tion in a wild-type offspring from a cross between an FVB/
N female and a Cast-7 male. We conclude from this anal-
ysis that a significant rescue of the methylation defect due
to the absence of the oocyte's Dnmt1o protein occurred
when Dnmt1s protein was overexpresed in fully grown
oocytes.
The improvement in H19 paternal allele methylation and
Snurf/Snrpn  maternal allele methylation in offspring
when oocyte Dnmt1o is replaced with Dnmt1s is associ-
ated with an improvement in imprinted gene expression.
In the same four embryos derived from Dnmt1∆1o/∆1o, TgEL
females, in which allele-specific DNA methylation was
examined, two of the four embryos (Embryo #2 and
Embryo #4) showed abnormal biallelic expression of
H19. The remaining two embryos (Embryos #1 and
Embryo #3) showed the normal monoallelic H19 expres-
sion from the maternal allele (Figure 5C). One of the
embryos (Embryo #2) with biallelic H19 expression also
showed biallelic Snurf/Snrpn expression. The other three
embryos showed monoallelic expression or near monoal-
lelic expression from the paternal Snurf/Snrpn allele. In
contrast, all four of the examined adult mice from
Dnmt1∆1o/∆1o, TgEL female mice showed normal monoal-
lelic  H19  expression. Only one of these (Adult #3)
showed evidence of abnormal expression of Snurf/Snrpn
from both parental alleles. We conclude from this analysis
that oocyte-derived Dnmt1s is capable of a complete or
partial functional substitution of the normal oocyte
Dnmt1o protein.
Discussion and Conclusions
Dnmt1 and the inheritance of genomic imprints
Imprinted genes have stringent epigenetic requirements.
Arguably, the most important of these is the inheritance of
highly methylated alleles whose parent-specific methyla-
tion was established during gametogenesis [1]. The inher-
itance of this gametic methylation is particularly
noteworthy during preimplantation development. Here,
highly methylated alleles maintain their methylation in
the face of significant rearrangements of genomic DNA
methylation. These rearrangements include the loss of
methylation on non-imprinted gene sequences, the main-
tenance of CpG methylation on classes of repetitive
sequences, and a significant overall loss of gametic meth-
ylation [12-14].
The DNA sequences carrying the inherited imprinted
methylation are called differentially methylated domains
(DMDs) [1]. DMD methylation must be accurately inher-
ited at every S phase of every embryonic cell cycle in order
to sustain the DMD methylation in every cell of the devel-
oping embryo. This may be particularly true of preimplan-
tation development. Here, the consequences of not
inheriting DMD methylation for even one S phase are
severe, as exemplified by a 50% reduction of imprinted
methylation and fetal death in the absence of the mater-
nal-effect Dnmt1o protein [5]. One can easily imagine
that the loss of other components of the machinery con-
trolling the inheritance of DMD methylation in the pre-
Table 1: 
Percentage Methylated CpGs
Mouse Genotypea Embryo/Adult 
Number
H19 Snurf/Snrpn
M a tP a tM a tP a t
Dnmt1+/+ 39 3 9 10
Dnmt1∆1o/+ 35 7 d 44d 1
TgEL/+ 2 92b 92b 4
Embryo 1 9 88b 89c 4
Embryo 2 13 69c 79b 4
Embryo 3 8 87b 73b 1
Dnmt1∆1o/+, TgEL/+ Embryo 4 0 54c 84b 2
Adult 1 0 71b 93b 3
Adult 2 1 87b 77b 11
Adult 3 17 85b 93b 5
Adult 4 11 82b 96b 0
a Dnmt1∆1o/+ embryo is from a cross between a Dnmt1∆1o/∆1o female mouse and a Cast-7 male; Dnmt1∆1o/+, TgEL embryo is from a cross between a 
Dnmt1∆1o/∆1o, TgEL female mouse and a Cast-7 male.
b No significant difference compared to Dnmt1+/+ methylation
c Significant difference compared to Dnmt1+/+ methylation (p < 0.05)
d Significant difference compared to Dnmt1+/+ methylation p < 0.025)BMC Developmental Biology 2008, 8:9 http://www.biomedcentral.com/1471-213X/8/9
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implantation embryo would lead to similar catastrophic
effects.
Most of the molecular machinery that ensures the inherit-
ance of imprinted DMD methylation during preimplanta-
tion development is unknown. At the very least,
maintenance methyltransferase activity would be required
at every S phase. There are approximately seven S phases
of preimplantation development, and the maintenance
methyltransferase activity of only one of these S phases
has been identified. This is the fourth S phase, whose
methyltransferase activity is attributed to the oocyte-
derived Dnmt1o protein [5]. We had previously only been
able to observe Dnmt1s in 4-cell, 8-cell and 16-cell abnor-
mal embryos in which Dnmt1o protein was absent [7].
We have now shown here that Dnmt1s is present through-
out preimplantation development, and present in the
nucleus at nearly all of these stages. In support of this, the
presence of preimplantation Dnmt1s protein has been
recently reported by other investigators [15]. Because of
this, we propose that Dnmt1s maintains imprinted DNA
methylation patterns at the other S phases of preimplana-
tion development.
Different forms of Dnmt1
Dnmt1 proteins found in oocytes and preimplantation
embryos are primarily distinguished by size. In the
mouse, the Mr  190,000 Dnmt1s protein contains the
entire peptide sequence of the Mr175,000 Dnmt1o pro-
tein; the larger size of Dnmt1s is due to an additional 118
amino acids at the amino terminus (Figure 1A). In the
wild-type mouse, Dnmt1o is synthesized only in the
oocyte, and functions in the inheritance of genomic
imprints when it traffics into the nuclei of 8-cell embryos
(fourth S phase). As shown here, Dnmt1s is synthesized in
both oocytes and preimplantation embryos. These obser-
vations suggest that the combination of Dnmt1o and
Dnmt1s proteins from the oocyte, and Dnmt1s protein
from the preimplantation embryo work together to
ensure the accurate inheritance of DMD methylation (Fig-
ure 6).
As indicated above, in addition to Dnmt1 proteins of dif-
ferent sizes, Dnmt1 proteins also come from different
developmental sources. This raises the issue as to whether
oocyte and preimplantation Dnmt1 proteins are primarily
distinguished in their functions by amino acid sequence
or by their developmental source (oocyte versus embryo).
Two experiments indicate that the important distinction
between the Dnmt1o and Dnmt1s proteins is most likely
their different developmental sources. First, an oocyte-
derived, epitope-tagged version of Dnmt1s restores
imprinting in the absence of Dnmt1o (Figure 5 and Table
1). This indicates that oocyte-derived Dnmt1s functions
in the absence of oocyte-derived Dnmt1o. Presumably,
when Dnmt1s is synthesized to levels significantly greater
than found in wild-type oocytes, it can persist in sufficient
quantities to the 8-cell stage, traffick into the blastomere
nuclei and maintain genomic imprints. The inefficiency of
this maintenance is likely due to the difference in preim-
plantation stabilities between oocyte Dnmt1o and
Dnmt1s (Figure 2B). A marked difference in stability of
the two proteins is also seen in heterozygous Dnmt1V
somatic cells that synthesize both Dnmt1s and Dnmt1o
proteins [8].
The second observation supporting a functional differ-
ence between maternally and zygotically synthesized
Dnmt1 proteins is the viability of homozygous Dnmt1V/V
mice. Dnmt1o protein expressed from the Dnmt1V alleles
in these homozygous Dnmt1V/V mice maintains inherited
methylation patterns in the absence of both maternal and
zygotic Dnmt1s. The interchangeability of Dnmt1o and
Dnmt1s proteins during preimplantation development is
inconsistent with a meaningful difference in maintenance
methyltransferase function of the two proteins. It is con-
sistent, however, with a primary functional difference
Model of Dnmt1o and Dnmt1s protein expression during  preimplantation development Figure 6
Model of Dnmt1o and Dnmt1s protein expression 
during preimplantation development. A. The top row 
of schematics depicts the pattern of maternal Dnmt1o pro-
tein expression seen during preimplantation development. 
Dnmt1o is localized in the nucleus of blastomeres of 8-cell 
embryos. Dnmt1o is not found in the pronuclei. B. The mid-
dle row of schematics depicts the pattern of maternal 
Dnmt1s protein expression in the early stages of preimplan-
tation development. Dnmt1s is not found in the pronuclei. C. 
The bottom row of schematics depicts the pattern of zygotic 
Dnmt1s protein expression during preimplantation develop-
ment. Dnmt1s is evident in nuclei of many stages, including in 
blastomeres of 8-cell embryos.BMC Developmental Biology 2008, 8:9 http://www.biomedcentral.com/1471-213X/8/9
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between maternal (oocyte-synthesized) and zygotic
(embryo-synthesized) Dnmt1 proteins.
Potential functions of Dnmt1 proteins
The 8-cell preimplantation embryo highlights the func-
tional difference between oocyte- and embryo-derived
Dnmt1 proteins. The fourth cycle of embryonic DNA rep-
lication occurs at this cleavage stage. In all likelihood,
methylation of DMD sequences is maintained immedi-
ately following DNA replication at this fourth S phase.
Although both the Dnmt1o and the Dnmt1s proteins are
present in nuclei of 8-cell blastomeres (Figure 4) [5], only
the Dnmt1o protein provides maintenance methyltrans-
ferase activity to maintain DMD methylation. A signifi-
cant loss of DMD methylation occurs even though
Dnmt1s is seen in nuclei of 8-cell Dnmt1∆1o  mutant
embryos that are devoid of Dnmt1o [7,5]. Because of this,
we can conclude that the persistent zygotically synthe-
sized Dnmt1s protein is unable to replace the normal
Dnmt1o maintenance function.
An unexpected observation of these studies was the
absence of Dnmt1s and Dnmt1o proteins in the pronuclei
of 1-cell embryos (Figures 3B and 3C). Dnmt1s is seen
only in the cytoplasm of all pronuclear-stage embryos,
including mutant ones that express more Dnmt1s protein,
and the abundant Dnmt1o protein is only in the cyto-
plasm of wild-type pronuclear-stage embryos. Both pro-
teins must, therefore, not be imported into the pronuclei
or be actively exported from the pronuclei into the cyto-
plasm of the 1-cell embryo.
DNA replication occurs during the latter stages (PN3 and
PN4) of pronuclear changes, prior to the breakdown of
the pronuclear membranes [16,17]. This indicates that, if
Dnmt1s provides the maintenance methyltransferase
function in association with the first replication cycle, it
does so after pronuclear breakdown. Dnmt1 maintenance
methyltransferase activity is generally closely associated
with DNA replication, both in its timing and the intranu-
clear co-localization of Dnmt1 with replication machin-
ery [18]. Therefore, a delay between DNA replication and
maintenance methylation in 1-cell embryos would be
unexpected [19]. Moreover, given the brevity of the G2
phase of the first embryonic cell cycle [13], the absence of
pronuclear Dnmt1 proteins might indicate that mainte-
nance methylation actually occurs in the G1 phase of the
next (second) embryonic cell cycle.
Except for the nuclei of blastomeres of 8-cell embryos,
embryo-derived Dnmt1s is the sole nuclear Dnmt1 pro-
tein from the 4-cell embryo stage, onward. Therefore, it
would appear to be an ideal candidate for catalyzing the
maintenance of DMD methylation at the corresponding S
phases. However, if embryo-derived Dnmt1s cannot
maintain imprinted DMD methylation at the fourth S
phase, can it maintain imprinted DMD methylation at
other S phases? The answer to this question is unknown.
However, if it does indeed maintain DMD methylation at
stages other than the 8-cell stage, this suggests that the
same protein functions differently in the nucleus at differ-
ent cleavage stages, or alternatively that the Dnmt1s pro-
tein in the nucleus at a non-8-cell stage is not the same as
the Dnmt1s protein at the 8-cell stage. Very different mod-
els are needed to explain these two possibilities. In the
first case, factors other than the Dnmt1s protein itself,
such as DNA structural differences or proteins other than
Dnmt1, would have to be involved as part of the mainte-
nance mechanism. In the second case, possibly the more
interesting one, processes than expand the actual variety
of Dnmt1s proteins, would have to be invoked. Processes
to consider are transcriptional or post-transcriptional
processes that provide a variety of mature Dnmt1s tran-
scripts or post-translational processes that directly modify
Dnmt1s proteins. In this regard, splicing variants of
Dnmt1 transcripts that produce variant Dnmt1 proteins,
and post-translational serine phosphorylation of Dnmt1s
have been reported to occur in adult somatic cells [20-
22,19]. Whether similar processes that can expand the
forms of Dnmt1 proteins exist in oocytes or preimplanta-
tion embryos is presently unknown.
Taken together our results indicate that Dnmt1s is
expressed in all diploid-nuclear stages of mouse preim-
plantation embryos, suggesting that Dnmt1s provides
maintenance methylation activity for the inheritance of
methylation imprints in the early mouse embryo. The
combination of Dnmt1o and Dnmt1s proteins from the
oocyte and Dnmt1s protein from the preimplantation
embryo work together to ensure the accurate inheritance
of genomic imprints.
Methods
Animals
The mutant Dnmt11s/1o allele was constructed by inserting
coding sequences for the amino terminus of the Dnmt1s
protein into exon 1o of the Dnmt1 gene [6]. The Dnmt1∆1o
allele was generated by the targeted deletion of exon 1o
[5]. The Dnmt1V allele was constructed by mutating the
Dnmt1s initiation codon in exon 1s of the Dnmt1s gene
[8]. Dnmt11s/1o and Dnmt1V alleles were maintained in the
C57Bl/6 background, and the Dnmt1∆1o allele was main-
tained in the inbred FVB/N background. Cast-7, an inbred
consomic C57Bl/6 strain containing a M. mus castaneus
chromosome 7, was provided by Dr. Marisa Bartolomei.
All experiments on mice conformed to the policies of the
University of Pittsburgh Institutional Animal Care and
Use Committee.BMC Developmental Biology 2008, 8:9 http://www.biomedcentral.com/1471-213X/8/9
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The DNA fragment to produce the TgEL transgenic mouse
line was constructed using a modified pcDNA3.1/HisB
plasmid (Invitrogen). The CMV promoter of pcDNA3.1
was replaced with a 6.5-kb mouse Zp3 promoter [23], and
a full-length mouse Dnmt1  cDNA was cloned into the
unique EcoRV site, adjacent to sequences coding for the
Anti-Xpress Epitope tag. A DNA fragment (Zp3-Dnmt1-
BGH) was released from the plasmid and injected into
pronuclei of inbred FVB/N zygotes. The TgEL line was
maintained in an inbred FVB/N background, except when
TgEL-containing lines were crossed to Cast-7 male mice.
Fully grown, germinal vesicle (GV)-stage oocytes were
obtained from ovarian follicles of 21- to 35-day-old
females. Metaphase II (MII) oocytes were collected from
females superovulated by injection of pregnant mare
serum gonadotropin (PMSG) (Calbiochem, LaJolla, CA),
followed 44–48 hours later by human chorionic gonado-
tropin (hCG) (Sigma) and cumulus cells were dispersed
with 1 mg/ml hyaluronidase (Sigma). Preimplantation
embryos at the 2-cell stage were isolated from the oviducts
at 1.5 days post coitum (dpc); 4-cell embryos; 8-cell
embryos and morulae were isolated from oviducts
between 2 and 3 dpc. Blastocysts were isolated from the
uterus at 3.5 dpc. All oocytes and embryos were collected
in M2 medium (Specialty Media) followed by a wash in
1× PBS.
Immunoblotting
Oocytes and preimplantation embryos were lysed in 0.1
M Tris HCl (pH 6.8), 20% glycerol, 2.5% β-mercapthoeth-
anol, 4% SDS, 0.02% bromophenol blue (2× sample
buffer). Samples were denatured by heating at 95°C and
then separated by electrophoresis on SDS-5% polyacryla-
mide gels. Afterwards, they were transferred to PVDF
membranes (Immobilon-P Millipore). Membranes were
blocked in 5% dry skim milk in 0.1% Tween-20 PBS (PBS-
T) for 1 hour and probed with UPT82 (1:1,000), or
UPTC21 (1:1,000) overnight at 4°C. Following 5 washes
of 5 minutes each in PBS-T, the membranes were incu-
bated for 1 hour in donkey anti-rabbit IgG (Amersham)
diluted 1:10,000 in blocking solution, or rabbit anti-
chicken IgY (Promega) diluted 1:5,000 in blocking solu-
tion. Membranes were washed as above. Bound antibody
was detected using the chemiluminescence detection kit
ECL Plus (Amersham). When a blot was reprobed with a
different primary antibody, the first antibody was
removed by incubation with stripping solution and then
the blot blocked for 1 hour at room temperature. Compar-
isons in the intensity of antibody binding between any
two lanes on the same immunoblot were determined
using a PDSI Scanner (Amersham Bioscience) and Image-
Quant 5.2 software.
Immunocytochemistry
Oocytes and preimplantation embryos were freed of the
zona pellucida using acidified Tyrode's medium, washed
with PBS and transferred to a cover slide treated with poly-
L-lysine (Sigma-Aldrich), then fixed for 10 minutes at
room temperature in 3.7% formaldehyde in PBS. The
fixed cells were blocked for 1 hour in blocking buffer (3%
BSA, 0.1% Triton-X100) and then incubated in either
UPT82 (1:250) or UPTC21 (1:100), diluted in blocking
buffer, overnight at 4°C in a humidified chamber. Follow-
ing 3 washes of 5 min each in blocking buffer, the samples
were incubated in 1:100 of donkey anti-rabbit IgG fluo-
rescein (FITC)-conjugated (Jackson Immunoresearch) or
in 1:250 of goat anti-chicken IgG Alexa Fluor 488 (Molec-
ular Probes) for 1 hour, and washed as before. The cover
slide with the cells was placed on a glass microscope slide
with a drop of Vectashield mounting medium (Vector
Laboratories, Burlingame, CA) supplemented with 0.4 ug/
ml of the DNA-binding dye DAPI. Immunofluorescence
was visualized using a Leica SP2 Laser Scanning confocal
microscope using 63X lens. All images were recorded
under identical laser conditions.
Fibroblasts from heterozygous Dnmt1V/+ or homozygous
Dnmt1V/V embryos were grown on glass coverslips. The
cells were permeabilized for 20 minutes in 0.5% Triton X-
100 in PBS. UPT82 was used at a concentration of 1:100
in PBS. A goat anti-rabbit secondary antibody conjugated
to Texas Red (Molecular Probes) was used. All washes
were performed with 1× PBS and incubation and wash
times were identical to those used for oocyte and embryo
staining described above. Immunofluorescence was visu-
alized with a Leica DMI4000 fluorescence microscope.
DNA methyltransferase activity and allele-specific DNA 
methylation
The methyltransferase activity assay, with the following
modifications, was adapted from Issa et al. (1993). The
reaction mixture was extracted with phenol:chloroform,
using phase-lock gels (Eppendorf), and the filters washed
eight times with 5% cold trichloroacetic acid and thrice
with 70% ethanol. The radioactivity on the filter was
measured with a liquid scintillation counter. Pools of 20–
40 oocytes were used for each reaction.
Bisulfite genomic sequencing was performed as described
[24]. PCR primers to the 5' regions of two genes (H19,
GenBank accession number U19616, nucleotides 1301–
1732; and Snurf/Snrpn, GenBank accession number
AF081460, nucleotides 2151–2562) were synthesized,
and parental alleles were distinguished by single-nucle-
otide polymorphisms in crosses between FVB/N and Cast-
7 strains. DNA was prepared from adult skeletal muscle or
brain, or from entire E13.5 embryos. Nested PCR reac-
tions were necessary to obtain sufficient product from theBMC Developmental Biology 2008, 8:9 http://www.biomedcentral.com/1471-213X/8/9
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treated genomic DNA. PCR products were electro-
phoresed on a 1% agarose gel and isolated PCR fragments
were subcloned into the TOPO-TA pCR2.1 vector (Invitro-
gen, Carlsbad, CA) for sequencing. Statistical differences
in methylation of CpG dinucleotides of imprinted genes
were evaluated using a paired Student T-test.
Allele-specific gene expression
The same embryos and adult survivors used for methyla-
tion analysis were used in studies of imprinted gene
expression. RNA was extracted from adult skeletal muscle
or brain, or from entire E13.5 embryos by using the
UltraSpec RNA extraction kit on frozen and pulverized tis-
sues (Biotecx, Houston, TX). cDNA was synthesized using
the M-MLV kit (Promega, Madison, WI). All assays were
dependent on the presence of distinguishing polymor-
phisms between the two parental alleles. Either RNA from
whole E13.5 embryos or adult skeletal muscle was used
for analysis of H19 expression. H19 was PCR amplified
using specific H19 primers, H19 forward 5' CCT CAA GAT
GAA AGA AAT GGT 3' and H19 reverse 5' AAC ACT TTA
TGA TGG AAC TGC 3' [25] in the presence of α-
[32P]dCTP. The PCR product was digested with CaC8I and
run on a polyacrylamide gel. Bands were visualized using
auto-radiography. RT-PCR products from the Cast-7 allele
contained a CaC8I restriction site, resulting in a 148-bp
band, whereas products from the FVB/N allele did not,
resulting in the full-length PCR product of 648 bp. For
Snurf/Snrpn, RNA from either whole embryos or adult
brain was used and expression was analyzed by the single
nucleotide primer extension (SNuPE) technique as previ-
ously described [26-28,6]. After electrophoresis of the
samples on a 15% denaturing gel, bands were visualized
by autoradiography. The incorporation of dGTP indicated
the expression of the FVB/N allele, while incorporation of
dATP indicated the expression of the Cast-7 allele
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